News & Updates

Show Multimedia Only
Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients

05 Jan 2022

In patients with Kawasaki disease, every day that intravenous immunoglobulin (IVIG) treatment is delayed aggravates the risk of developing coronary artery aneurysms (CAA), a recent study has found.

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients

05 Jan 2022
STEMI hospitalizations down during pandemic

STEMI hospitalizations down during pandemic

26 Dec 2021
Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS

Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS

25 Dec 2021

For older acute coronary syndrome (ACS) patients with implanted bioabsorbable polymer sirolimus-eluting stents, a strategy involving ticagrelor monotherapy after 3‐month dual antiplatelet therapy (DAPT) is better than ticagrelor‐based 12‐month DAPT, according to a post hoc analysis of the TICO* trial. Furthermore, the beneficial effect of ticagrelor monotherapy increases with age and is strongest among patients aged ≥64 years.

Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS

25 Dec 2021
Statin adherence a must to reduce stroke risk among hyperlipidemia patients

Statin adherence a must to reduce stroke risk among hyperlipidemia patients

24 Dec 2021

Patients with hyperlipidemia who take their statin medication as prescribed appear to do well, with treatment adherence conferring significant protection against the risk of ischaemic and haemorrhagic strokes, as reported in a study.

Statin adherence a must to reduce stroke risk among hyperlipidemia patients

24 Dec 2021